In addition, expression profiles of CDK2 and CDK4 were associated with tumor metastasis (Figure 1A) and breast cancer subtypes, with higher expression levels in basal and Her2 subtypes than the other subtypes (Figure 1B). Here, ERBB2 is linked to breast carcinoma.